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Abstract
The laboratory mouse is the pre-eminent model organism for the dissection of human disease pathways. With the advent of
a comprehensive panel of gene knockouts, projects to characterise the phenotypes of all knockout lines are being initiated.
The range of genotype-phenotype associations can be represented using the Mammalian Phenotype ontology. Using
publicly available data annotated with this ontology we have constructed gene and phenotype networks representing
these associations. These networks show a scale-free, hierarchical and modular character and community structure. They
also exhibit enrichment for gene coexpression, protein-protein interactions and Gene Ontology annotation similarity. Close
association between gene communities and some high-level ontology terms suggests that systematic phenotyping can
provide a direct insight into underlying pathways. However some phenotypes are distributed more diffusely across gene
networks, likely reflecting the pleiotropic roles of many genes. Phenotype communities show a many-to-many relationship
to human disease communities, but stronger overlap at more granular levels of description. This may suggest that
systematic phenotyping projects should aim for high granularity annotations to maximise their relevance to human disease.
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Introduction
With the advent of well-annotated genome sequences for
humans and other mammals the focus of genetic analysis is
turning to the relationship between phenotype and genotype. The
laboratory mouse is central to this analysis because of its ease of
genetic manipulation and short generation time [1]. Mouse
genetics has a history of over 100 years and has accumulated a
large repository of information on mouse genes and the
phenotypes associated with them [2]. As a model organism, the
laboratory mouse benefits from a comprehensive set of gene
function information that it is not possible to obtain in humans and
therefore represents a unique opportunity for more comprehensive
analyses in a mammal. However gaining an overview of gene-
phenotype relationships is difficult using individual database
searches [3]. There is therefore a need to develop a structure
within which these relationships can be investigated in an
integrated way.
Phenotype description in the mouse differs from that in humans
in focusing on individual observable phenotypes rather than
diseases, which are less clear-cut entities [4,5]. A major strength of
mouse phenotype data is the common use of a well-developed
ontology to describe abnormal mouse phenotypes, the Mamma-
lian Phenotype ontology (MP) [6]. This ontology, which is made
up of 10,751 terms and 16 levels (as of 12.11.2010), contains most
of the terms used by mouse geneticists to characterize abnormal
mouse phenotypes. There are currently two major repositories for
mouse phenotype information which hold phenotype information
on genes annotated with MP: the Mouse Genome Database [2],
which collects manually curated annotations for mouse genes, and
EuroPhenome [7], which is a repository of the results of high-
throughput phenotyping screens. A natural way to integrate
phenotype and genotype data is to construct a bipartite graphical
structure consisting of genes and terms from the MP, thereby
linking MP terms by shared genes and genes by shared MP terms,
in a manner analogous to the gene-disease network structure
developed by Goh et al [8] for humans.
Goh et al [8] identified a number of significant features in their
disease-gene network, in particular a tendency for genes
associated with similar disorders to interact at the protein level
and to show coexpression. Following on from this analysis, much
emphasis has been placed on the prediction of gene function
(normally in the form of Gene Ontology (GO) [9] terms),
particularly in the context of genome-wide association studies.
Butte and Kohane [10] related differentially expressed genes to
disease, phenotype, experimental context and environment terms
contained within gene annotations, emphasising the use of MeSH
(Medical Subject Heading) terms to structure unstructured
textual annotations. Disease-gene networks have also been
applied to the problem of prioritising potential disease genes
[11,12,13]. More broadly, Marcotte and co-workers have
developed genome-wide functional gene networks using data
from a variety of species to predict genes associated with
particular phenotypes [14,15,16].
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systematic assessment of methods for predicting mouse gene
function has shown the value of network-based approach in gene
function prediction [17,18]. Guan et al [19] generated a Bayesian
network linking PPI, phenotype, disease, gene expression and
phylogenetic profiles with the aim of functionally linking mouse
genes and predicting gene function and pathway components.
They found a strong dependence between MP phenotype terms
and disease terms and so combined them for use in function
prediction. In an alternative approach to cross-species linking of
phenotype terms, Groth et al developed a text-, rather than
ontology-based approach [20].
Network structures have a range of possible applications beyond
the prediction of gene function. Whereas gene function prediction
is important for the molecular dissection of phenotype and disease,
the initial identification of disease models in the mouse (and other
model organisms) usually starts by the identification of phenotypes
in the model organism which mirror phenotypes associated with
diseases in humans. These are then used as an access point to the
genes and pathways involved in these pathways (forward genetics).
It is therefore important to develop a formal link between
phenotype ontologies and genes in order to characterise the
relationship between phenotypes and their underlying genetics,
and to allow best use to be made of gene annotations arising from
projects, such as EUMODIC (http://www.eumodic.org/), which
aim to systematically phenotype knockouts of every gene in the
mouse genome. In this paper we explore the direct linking of MP
terms to genes. Here we describe a gene-phenotype network
constructed defined using mouse data from the MGD and
Europhenome databases which links genes by shared MP terms
and MP terms by shared genes. We compare the structure of this
network with the human disease network and evaluate its utility for
phenotype prediction and analysis and ontology refinement.
Results
Annotation granularity in the MP Ontology and GO
Unlike the construction of disease-gene bipartite networks [8],
which simply involves linking gene names or identifiers with
disease names, construction of a mouse gene-phenotype network
requires the linking of MP ontology terms to gene names and IDs.
The MP ontology (like other ontologies including the GO [9]) is
structured such that terms have relationships between them so as
to form a directed acyclic graph (DAG), allowing for varying levels
of descriptive granularity. The ontologies are therefore organised
into levels with different degrees of granularity. This introduces an
additional level of complexity into the analysis. We therefore firstly
considered the use of the different granularity levels of MP and
GO ontology terms for annotation in two primary data sources.
The level immediately nearest the root of an ontology’s DAG is
termed level 1. This is the highest level and contains the most
broad, generally descriptive (least granular) terms in the ontology.
Specific (more granular) terms are labelled as lying at increasing
level numbers corresponding to the number of nodes lying above
them in the ontology’s hierarchy. MP (and GO) annotations for
mouse employ mixed levels of ontology terms. We therefore
characterised the most frequent level of annotation used. To do
this for MP terms we used MGD, which contains the largest public
domain corpus of MP annotations. The results are presented in
Figure S1. The MP ontology showed a single peak of most
frequent annotation at level 5. We therefore focussed on MP level
5 in the subsequent analysis and we also considered MP level 8,
after which annotation usage declines sharply, to characterise the
effect of using a more granular level of annotation on the overall
results. These levels also provided a compromise between
granularity and retention of annotations. To inform analysis of
GO terms associated with genes, we also considered the levels of
the three GO sub-ontologies used in gene annotation in Ensembl.
The ‘‘biological process’’ (BP) of the GO also showed a single peak
of most frequent annotation at level 5. However the ‘‘cellular
component’’ (CC) of GO showed two peaks at levels 2 and 5 while
the ‘‘molecular function’’ (MF) of GO has three peaks at levels 2,
4, and 6. We therefore used level 5 of the BP and CC branches of
the GO and level 2 of the MF branch to investigate functional
enrichment of gene communities.
Characterisation of the mouse gene-phenotype network
Global views of the mouse gene-phenotype network (GPN)
constructed using level 5 MP terms and their associated Ensembl
gene identifiers are illustrated in Figure 1. The composition of
these networks depends on whether genes or phenotypes are
considered, the MP level considered, and the cut-off value of the
association weight d used to accept edges into the network (see
Methods for definition of d). Different d cut-offs were applied for
different networks and different ontology levels (see Methods).
Applying these cut-offs greatly reduces the coverage of the gene set
in the network compared to using no cut-off (i.e. dcutoff=0). We
observed reductions from 4996 to 430 (level 5; dcutoff=0.009) and
2625 to 378 (level 8; dcutoff=0.011) for gene networks and from
1269 to 239 (level 5; dcutoff=0.005) and 512 to 199 (level 8;
dcutoff=0.002) for phenotype networks.
Figure 1 (A&B) shows the GPN as a gene network linked by
phenotype terms. Figure 1A labels genes with their highest-
scoring level 1 MP term to illustrate clustering of similar
phenotypic outcomes within the network (see Materials and
Methods for a description of the scoring process used to assign
these terms), while Figure 1B is colour-coded according to
communities (clusters) identified by the Newman spectral method
[21]. Figure 1 (C&D) shows this network as a phenotype
network linked by genes. Again, colour-coding is by Level 1 MP
term in Figure 1C and Newman community in Figure 1D.
For both gene and phenotype networks there is a close but not
perfect correspondence between Newman communities and
regions of the graph coloured according to most common Level
1 MP term, suggesting that the GPN has a broadly modular
nature. This is illustrated using a small number of sub-networks of
interest in the Supplementary material (Figure S2). The full
underlying data are presented as electronic supplementary text
(Text S1 & S2). Corresponding networks constructed using Level
8 MP terms are shown in Figure S3.
The correspondence between Newman communities and MP
terms is shown clearly in the heat map representations shown in
Figure 2, which represent Level 1 MP term frequencies across
Newman communities. Some communities, notably communities
0, 5, 2 and 1, and to a lesser extent 4, showed a close mapping to
individual MP terms. Others, however, showed only weak
mappings to single MP terms and some little or no such mapping.
Conversely, ten Level 1 MP terms showed no assignation to
communities. MP Level 1 terms which form discrete communities
are shown in Table S1.
Topological properties of the GPN
Biological networks characteristically have a scale-free and
hierarchical nature [22]. The gene network at level 5, when parsed
using a dcutoff of 0.009, showed both of these properties (Figure 3
A–B). Scale-freeness is indicated by the linear nature of the log-log
plot of P(k) against k (Figure 3A), while hierarchical nature is
indicated by the linear log-log plot of C(k) vs k (Figure 3B) [22].
Mouse Gene-Phenotype Network
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constructed using level 8 MP terms are presented in Figure S4.
When no cut-off is applied (dcutoff=0) the gene networks showed
reduced scale-free character, switching to a mixed degree
distribution type, i.e. containing varying proportions of scale-
freeness and random network character (represented by normally
distributed values of k) (Figure S5, A–B, D–E, G–H). The
network constructed using level 1 MP terms was almost random in
nature. The hierarchical character of the network is retained at
level 1 with dcutoff=0 but gets progressively lost at lower levels
(Figure S5, C,F,I).
The phenotype network at level 5 also showed a scale-free
character and weak hierarchical character (Fig. 3 C–D). Again,
the log-log plot of C(k) vs k was non-linear, as seen for the gene
network. At dcutoff=0 the scale-free character was lost as for the
gene network but a weak hierarchical character remained (Figure
S6). A phenotype network constructed for Level 1 MP terms
showed very high connectivity, most likely indicative of extensive
pleiotropy in the system (Figure 1E).
Modularity in the GPN
Visualisation of the level 5 gene network at dcutoff=0.009 results
in the appearance of visually discernable modules (Figure 1A),
consistent with a functional modularity in the mouse genetic
machinery. Newman’s algorithm [21] identified 10 communities
in the level 5 gene network (Figure 1B) and 8 communities in the
level 8 gene network. MP terms also naturally arrange themselves
into visibly discernible clusters in the level 5 phenotype network
(Figure 1C). In this case Newman’s algorithm gave 7 commu-
nities in the level 5 network (Figure 1D) and 9 communities in the
level 8 network (Figure S3 and Table S1).
To test if the modular character of the gene and phenotype
networks was significantly greater than that of randomly wired
networks we simulated randomly re-wired versions of the networks
that kept the same node degree distribution (n=1000). The
empirical networks showed significantly higher clustering coeffi-
cients and Newman’s Q values compared to these simulated
networks (p%0.001 in all four cases) (Figure S7). A stringent
threshold on edges (on the order of d$0.005–0.009) is needed to
produce visually or computationally discernible communities in
the mouse GPN (compare, for example, Figures 1C and 1E).
Functional enrichment and phylogenetic profiles of
communities and hubs extracted from the gene network
Goh et al [8] identified significant overrepresentation of
coexpressed genes and gene interactions at the protein level in
disease-associated modules in a human disease-gene network. To
test if the communities in the gene network at dcutoff=0.009
correspond to components of similar functional modules we tested
them for various measures of functional enrichment. Communities
showed higher co-expression compared to random controls both
for microarray RNA levels (Figure 4A)( p %0.001) and tissue
expression patterns in GXD (Figure 4B)( p %0.001). They also
show increased likelihood of having a physical interaction
(Figure 4C)( p %0.001) and increased GO term annotation
similarity at the relevant level of each sub-ontology (Figure 4D–F)
(p%0.001 for all three branches of the GO).
We hypothesised that genes that are highly connected within
their communities could act as regulators of function. To test this
hypothesis, we took the hub genes (defined as genes having more
connections than shown by 80% of all genes) from the gene
network at level 5 and investigated the overrepresentation of GO
terms within them. We found highly significant overrepresentation
of GO:0016563 ‘‘transcription activator activity’’ (p,0.001) and
weaker overrepresentation of GO:003682 ‘‘chromatin binding’’
(p,0.05), suggesting that highly connected nodes within commu-
nities tend to be involved in transcription regulation.
Functionally related proteins are believed to have correlated
patterns of gain and loss during evolution [23,24]. To test the
hypothesis that the genes in the gene communities identified here
coevolved we constructed phylogenetic profiles for all genes in
mouse using the Ensembl Compara database [25]. Genes within
communities showed a shift to higher correlation of phylogenetic
profiles compared to non-community genes (p%0.001) (Figure
S8) and this effect was stronger for Level 5 than level 8 MP terms.
Level 1 MP Term Enrichment within Gene Communities
If genes within communities tend to be functionally correlated,
we would expect them also to share similar phenotypic outcomes,
represented as MP terms. To test this we examined the numbers of
genes within gene or phenotype networks that shared or did not
share level 1 MP terms, taking into account whether or not they
were members of the same Newman community. Results of these
analyses are summarised in Table 1. Communities generally
showed a modest overrepresentation of genes with the same level 1
MP term. In terms of gross numbers, this excess generally gave rise
to highly significant Chi-squared values.
Comparison of mouse communities to human
communities
To assess the extent to which our communites exhibited overlap
with the communities from [8], we applied Newman’s method to
Goh et al’s human disease gene network and calculated the extent
of overlap between communities in the two networks. The results
of the pairwise comparisons are shown in Figure 5. There are
varying degrees of overlap between the two sets of communities. In
general, the extent of overlap is relatively high if missing data is
taken into account; the highest overlap scores reach approximately
0.6. However about half of the human communities had no
apparent equivalents in the mouse communities, perhaps as a
result of missing data. Comparing community mappings for the
MP level 5 and level 8 networks (Figures 5A & B) shows more
high-overlap matches for the MP level 8 network than for the level
5 network.
Figure 1. Visualisation of Gene and phenotype networks and communities. A) Gene network at MP level 5 using a threshold of
dcutoff=0.009. Colouring corresponds to the highest-scoring MP term at level 1 in the weighted biadjacency matrix. Vertices with more than one
equally high-scoring term are coloured in light grey. B) Gene network at MP level 5 using dcutoff=0.009 with colours indicating the communities
extracted with Newman’s spectral method. C) Phenotype network at MP level 5 using dcutoff=0.005. Colouring shows the most frequent parent MP
term at level 1 if the MP DAG is traversed. Vertices with more than one of these were coloured white. D) Phenotype network at MP level 5 using
dcutoff=0.005 with colours indicating the communities extracted with Newman’s spectral method. E) Visualisation of the phenotype network at MP
level 1 constructed with no d cut-off (dcutoff=0). This results in a highly-connected network. A&B: Vertices correspond to genes. Vertex size is
proportional to the sum of scores in the weighted gene6gene adjacency matrix, which corresponds to the amount of association it has with other
genes. Edges are proportional to the strength of association (edge weight in the adjacency matrix). B&C: Vertices correspond to MP terms in the MP.
Vertex size is proportional to the sum of scores in the weighted phenotype6phenotype adjacency matrix.
doi:10.1371/journal.pone.0019693.g001
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disease network community was community 6, which comprised
four genes whose orthologues are associated with McKusick-
Kaufman syndrome (MKKS) and the Bardet-Biedl syndrome
(BBS) [26] and showed overrepresentation of the MP terms
‘‘cellular phenotype’’, ‘‘pigmentation phenotype’’, ‘‘muscle phe-
notype’’ and ‘‘nervous system phenotype’’. This overlapped
strongly with community 39 of the disease network, five of whose
components were MKKS/BBS genes, including three MP
community 6 genes (75%). Other MP communities showed
broader mappings to a number of disease communities
(Figure 5), Table 2 presents the most common level 1 MP term
associated with each phenotype community along with the disease
term associated with the most strongly overlapping disease gene
community for the MP Level 5 GPN. There is generally a good
agreement between the two sets of terms. More detailed listings of
gene community memberships for the MP Level 5 network are
given in Dataset S1.
Hierarchical clustering of Level 1 MP terms
Given the relationship we observed between gene function and
MP terms we investigated whether information contained in the
network might be used to add structure to phenotype ontologies.
We carried out clustering of Level 1 MP terms according to shared
genes, assessing the significance of the clusters using approximately
unbiased p-values (AU) [27] (Figure 6). This produced seven
clusters with AU=1.00 and four additional clusters of AU$0.95
(including one which distinguished all phenotypes from
Figure 2. Mapping of communities to their most probable MP level 1 community based on gene membership overlap. Cells represent
2log(p) where p is the probability of assignment based on overlap of the communities in the gene network with the community membership based
on the most frequent MP level 1 membership. Red areas represent a low value and yellow areas represent high values. Dendrograms on the vertical
axes represent hierarchical clustering using euclidean distances. A) MP level 5 communities; B) MP level 8 communities.
doi:10.1371/journal.pone.0019693.g002
Figure 3. Topological properties of networks gene and phenotype networks at MP level 5. A) Gene network degree distribution and B)
clustering coefficient distribution for the gene network at MP level 5, dcutoff=0.009. C) Phenotype Network degree distribution and D) clustering
coefficient distribution for the phenotype networks at MP level 5, dcutoff=0.005. Black lines indicate a line of best fit using linear regression.
doi:10.1371/journal.pone.0019693.g003
Mouse Gene-Phenotype Network
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Figure 6 the composition of these clusters was generally in line
with biological intuition.
Discussion
Structural features of the mouse gene-phenotype
network
In order to investigate the relationships between genes and
phenotypes, and in particular the potential for systematic mouse
phenotyping to identify underlying genetic pathways, we con-
structed a bipartite network linking Mammalian Phenotype
ontology terms (MP terms) to associated genes using data from
the Mouse Genome Database [2], which contains manually
annotated data on mouse phenotypes taken predominantly from
the literature, and the EuroPhenome database [7], which is a
database of raw phenotyping data emerging from a number of
systematic phenotyping projects, notably EUMODIC (http://
www.eumodic.org) and assigned MP terms based on significant
deviation of the results of individual tests from results on control
animals [28]. Integration of these diverse data sets was only
possible because of a shared use of the MP for annotation. We
have confined ourselves to phenotype terms and gene identifiers in
this analysis as we wished to study this relationship specifically. We
did not consider individual alleles of genes (or their respective
genetic backgrounds) as our aim was to link genes to phenotypes
via their molecular products. Larger, more complex structures can
be constructed to include gene function information, gene
expression, protein-protein and gene-gene interactions and so on
[17,18,19]. Such structures have been successfully used to predict
some phenotypes resulting from gene perturbations in Saccharomyces
cerevisiae, Caenorhabditis elegans and Arabidopsis thaliana [14,15,16].
Biological networks are typically scale- free and hierarchical
[22]. That is, they contain a higher proportion of highly-connected
nodes than a random network (scale-free) and are composed of
separable modules, or communities (hierarchical). These proper-
ties are also seen in the mouse GPN but they are only seen if a
relatively stringent cutoff is applied to remove weak connections
(d$0.009 for the gene network; d$0.005 for the phenotype
network). If weak connections are included a highly-connected
graph lacking scale-freeness and with little hierarchical structure is
produced. This is consistent with the widely-held view that many
genes are pleiotropic, i.e. have effects on many different
phenotypes. Only by characterising the strongest gene-phenotype
links can we identify a more typical network organisation.
The parameter c, which is the exponent of the relationship
between the probability of observing k connections at a node and
the connection number (P(k)!k{c), is an important property of
biological networks [22]. Networks with values of c below 3 have
been shown to be dominated by hubs and have a high degree of
robustness to loss of individual nodes at random [22]. Both the
phenotype and gene networks derived from the mouse GPN had c
of the order of 1 (see Figure 3), suggesting that both networks are
robust and dominated by highly connected hubs. A further
property of biological networks is that they are hierarchical,
consisting of highly connected modules linked by less connected
nodes [22]. Hierarchical networks are characterised by a linear
relationship of the log-log plot of C(k), the clustering coefficient of
a node, and k, the node degree as seen in Figures 3, S4 and S5
for both the gene and phenotype networks we describe here. We
conclude that both the gene and phenotype networks are
hierarchical in nature when constructed using sufficiently stringent
d cut-offs. It should be noted, however, that we observed that both
the scale-freeness and hierarchical nature of the networks are lost
as lower stringency connections are used, resulting in the limit in a
highly interconnected structure (Figure 1E). This may again
reflect the highly interconnected (pleiotropic) nature of the genetic
networks underlying phenotypes, with many genes contributing,
albeit weakly, to many phenotypic outcomes.
In characterising their human disease-gene network, Goh et al
[8] showed that genes associated with similar disorders show an
increased propensity to mutual physical interactions and gene
coexpression. We investigated whether the gene communities
within the GPN showed similar features by considering gene
coexpression, tissue coexpression patterns in GXD, protein-
protein interaction and GO terms. In all cases we found highly
significant overrepresentation within modules, as would be
expected if the genes associated with particular MP terms were
themselves associated with specific underlying processes that give
rise to abnormal phenotypes when disrupted. We could also show
higher correlations of phylogenetic profiles within communities
than between non-community genes. This suggests that groups of
genes giving rise to particular characteristics of organisms have
coevolved, consistent with the observation that groups of
interacting proteins tend to show coevolutionary patterns of gene
duplication and sequence divergence [24].
As scale-free networks are dominated by hubs, and in particular
in light of evidence of gene coexpression within gene communities,
we characterised the network hubs (defined here as the top 20%
most connected nodes) in terms of their Gene Ontology
annotations. We found a strong overrepresentation of the term
‘‘transcription factor activity’’ in hubs, indicating that the
behaviour of individual communities may be regulated by
particular transcription factors and that these transcription factors
may be responsible for regulating the expression of particular
Table 1. Frequencies with which gene pairs within Newman
communities share level 1 MP terms compared to frequencies
for all genes.
Network
Same within
communities
Same
overall P(Chi Sq, 3dof)
Level 5, Genes 0.64 0.54 %0.001
Level 5, Phenotypes 0.41 0.29 %0.001
Level 8, Genes 0.71 0.72 NS
Level 8, Phenotypes 0.22 0.19 ,0.001
doi:10.1371/journal.pone.0019693.t001
Figure 4. Functional enrichment in Gene networks. A) Coexpression increase measured by Pearson’s correlation coefficient for genes within
communities (red) compared to a random control (black) for the gene network at level 5 shown in Fig. 1 (A&B). B) GXD Tissue expression similarity
increase for genes within communities (red) compared to a random control (black) for the gene network at level 5 shown in Fig. 1 (A&B). The
similarity metric used was Pearson’s correlation coefficient. C) Number of physical protein-protein interactions for genes within communities (red)
compared to a random control (black) for the gene network at level 5 shown in Fig. 1. D–F) GO annotation similarity using the most common level for
each of the GO ontologies for genes within communities (red) compared to a random control (black) for the gene network at level 5 shown in Fig. 1.
The levels used were 5, 5, and 2 for BP, CC and MF respectively. The similarity metric used was the d score obtained using the same method as for the
gene-MP term networks.
doi:10.1371/journal.pone.0019693.g004
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with many target genes tend to be essential genes, while essential
genes tend to be hubs in gene networks [8,30]. Thus high level
phenotypes may be controlled by a subset of transcription factors
which may have multiple targets and be essential. Interestingly,
around one third of gene knockouts in the Knockout Mouse
Project ES cell library characterised so far are embryonic lethal
[1]. It will be interesting to characterise these genes further as the
data set grows.
Gene communities and phenotype diffuseness
Whereas Goh et al [8] selected gene sets based on their disease
annotations we used an objective criterion [21] for identifying
modules within the GPN in this study. A benefit of this approach is
that it avoids ascertainment bias due to lack of data on certain
phenotypic domains, which is a well-known problem of datasets
not derived from systematic phenotyping, such as MGD. A
disadvantage of this approach is that only 10 communities are
observed within the level 5 gene network that roughly correspond
to particular level 1 MP terms, although there are 31 level 1
phenotypes in MP. In particular, whereas ‘‘immune system
phenotype’’, ‘‘hearing phenotype’’ and ‘‘reproductive system
phenotype’’ were always resolved into very tight groups this was
not the case for other terms. Further analysis of the networks (see
Figure 2) suggests that other level 1 phenotypes are more
‘‘diffuse’’ in their distribution across the network.
In comparing our networks with Goh et al’s [8] disease-gene
network we found a number of good correspondences between the
gene sets making up Newman communities in the two networks,
especially at the level of MP term and disease annotations (see
Figure 5; Table 2). The Newman communities in the disease-gene
network do not exactly correspond to diseases but we could
identify the most common disease term for each community and
relate it to the most common MP term in the MP term-gene
networks. This comparison reveals a good match between MP
terms and disease terms (Table 2). The mappings in Table 2 to
some extent resemble the phenologs described by McGary et al
[31]. Phenologs are phenotypes that are considered homologous
between species and defined by groups of orthologues which are
shared between phenotypes in different species. Our mappings
differ from phenologs as they are defined using gene communities
identified objectively in the network rather than sets of genes
annotated to a given phenotype.
The comparison in Figure 5 indicates that although individual
communities may map quite well, MP terms do not map directly
onto individual diseases. This is unsurprising as human diseases
are typically characterised by a constellation of atomic phenotypes
[4]. Mapping between disease terms (or disease endophenotypes)
and MP terms may be possible using networks of this kind
however. In this analysis we identified only ten communities in the
GPN at MP level 5 and eight at MP level 8, whereas many more
could be identified in the disease-gene network. Adding additional
data to the GPN may give rise to more communities, allowing a
closer mapping between mouse and human phenotype sets.
Interestingly, we observed more strong overlaps between pheno-
type and disease communities when we considered level 8 MP
terms than with level 5 MP terms. This deserves further analysis
but may suggest that it will be important to collect granular
phenotype data in systematic phenotyping programmes to allow
linking of individual mouse models to diseases.
The diffuse distribution of many level 1 MP terms in the gene
network (Figure 2) could be due to a number of not necessarily
mutually exclusive factors. It could in part represent the
incompleteness of the data set, both in terms of the genes that
have been characterised (N,5,000 annotated at MP level 5 or
higher) and the amount of phenotype information available for
individual genes – the bulk of the information represented in the
mouse GPN we present here comes from individual, ad hoc studies
which focus not only on individual genes but also on individual
phenotype domains, meaning that much phenotypic information
is likely to be missing from the data set. To eliminate this
incompleteness there is a strong argument for collecting systematic
phenotype data on as many mouse genes as possible [1] at as high
a granularity as possible.
Two other causes might contribute to the relative diffuseness of
many level 1 MP terms in the mouse GPN. Firstly, it might reflect
the more highly pleiotropic nature of these phenotype classes. If
this were the case it would suggest that forward genetic approaches
which make use of these more diffuse phenotypes will have more
difficulty in identifying consistent sets of underlying genes (e.g.
pathways). For some of the level 1 MP terms that do not associate
strongly with gene communities this seems reasonable – for
example ‘‘growth/size phenotype’’, ‘‘lethality-postnatal’’, ‘‘lethal-
ity-postnatal’’ or ‘‘life-span-post-weaning/aging’’. Other catego-
ries, however, might be expected to have a clear genetic basis, for
example ‘‘taste/olfaction phenotype’’ or ‘‘touch/vibrissae pheno-
type’’. These latter classes however have the fewest genotype
Table 2. Relationship between Level 1 phenotype terms
associated with gene communities in the Level 5 network and
the disease term associate with the most strongly overlapping
disease gene network.
Level 5
Community No MP term
Disease term of most
similar disease
community
0 Homeostasis/metabolism Diabetes mellitus
1 Immune system Severe combined
immunodeficiency
2 Hearing/vestibular/ear Deafness
3 Pigmentation/cellular/muscle Atopy, Ataxia
4 Skeleton Holoprosencephaly
5 Reproductive system Fanconi anemia
6 Nervous system Bardet-Biedl syndrome
7 Renal/urinary system Hypertension
8 Tumorigenesis Colon cancer
9 Cardiovascular system Hypertension
doi:10.1371/journal.pone.0019693.t002
Figure 5. Mapping of MP and human disease communities to show the signifiance level of their gene membership overlap. Cells on
the heatmap represent the significance of the overlap of the communities in the GPN and the disease-gene network. The intensities correspond to
2log(p) where p is the probability of the observed overlap under the null hypothesis of random assignment of genes to communities. Dark areas
have the highest values of 2log(p) while white areas represent a low value. Numbers along the x-axis are the reference numbers of the Newman gene
communities identified in the disease-gene network and numbers on the y-axis are the reference numbers of the Newman communities identified in
the GPN. A) MP level 5 communities; B) MP level 8 communities.
doi:10.1371/journal.pone.0019693.g005
Mouse Gene-Phenotype Network
PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e19693annotations in the MGI database (143 and 546 genotypes
respectively on 27.07.10) so it is possible that they had too few
connections to form significant communities in the GPN.
A third source of the diffuseness of many level 1 MP terms
across the GPN could be the structure of the MP ontology itself, as
it could reflect a lack of alignment between the phenotypes
represented at high levels of the ontology and underlying genetic
processes. The high level terms in the MP reflect mouse biologists’
intuitive views of the categories into which phenotypes should be
grouped. This does not necessarily bear any relationship to the
underlying processes giving rise to these phenotypes. Level 1 MP
terms which are diffuse on the mouse GPN might then be
unnatural groupings in the sense that they do not reflect
underlying processes. Perhaps, for example, the lower level terms
that make them up should be split into more than one higher level
term.
What might an ontology that more closely aligned phenotypes
to genetics look like? As a first attempt to address this we clustered
level 1 MP terms by the proportion of the underlying genes they
share. The result of this is illustrated in Figure 6. This structure
contains a number of groupings of Level 1 terms not present in the
ontology itself. These high-level clusters are generally consistent
with biological intuition, suggesting that such an approach might
be of value in giving a more realistic structure to high level MP
terms.
Conclusions
We have shown that constructing a mouse gene-phenotype from
published data allows us to identify functional modules related to
high-level phenotype terms in the Mammalian Phenotype
ontology. This supports the hypothesis that the mammalian
genome is organised into interconnected modules of physiological
and cellular function that have a direct read-out at the phenotype
level. This in turn indicates that systematic phenotyping in mouse
and other model organisms [1,32] has the potential to identify
protein complexes, coexpressed sets of genes or molecular
pathways underlying many phenotypes.
Our findings are mirrored in studies on other model organisms
such as that by Gunsalus et al in C. elegans [33] in which
phenotypic similarity of RNAi knockdowns of cellular defects in
early embryogenesis correlated positively with GO term sharing.
In the same study, phenoclusters of genes with correlated
Figure 6. Hierarchical clustering of MP level 1 phenotypes according to gene commonality. Using the biadjacency matrix of genes6MP
terms at level 1, a dendrogram was made using 1-cor() as a distance and average linkage as the agglomerative hierarchical clustering method
(nnbootstrap=1 610
4). Values in red indicate the approximately unbiased (AU) values associated with the cluster.
doi:10.1371/journal.pone.0019693.g006
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were found to be functionally enriched in specific GO functions,
displayed enriched amounts of physical protein-protein interac-
tions, and showed enriched expression correlation. A combined
network of phenotypic similarity, expression similarity and
protein-protein interaction parsed for retention of only edges
with two or more types of function gave topological clusters that
predicted shared GO terms with high specificity. Eight out of ten
proteins with unknown function that were experimentally
checked for localisation were consistent with the predicted
function. Studies in human cells such by Fuchs et al [34], in
which genes were clustered by high-throughput cellular mor-
phology screens, also provided phenotypic clusters that were
predictive of gene function and could be used to identify specific
functions for several genes.
In yeast, the model organism for which the largest number of
genetic interactions have been studied, comprehensive interaction
networks were made using a synthetic genetic array that
automated the isolation of double mutants [35]. The density of
the resulting interaction map mirrors our results, in which the gene
networks of phenotypic similarity are very densely connected for
high levels of the MP, suggesting greater connectivity which
transcends physical interactions [35]. Genes connected inside this
yeast gene network often shared GO term annotations and the
network could be used to predict protein-protein interactions.
In this study, a number of high-level terms in the MP show a
diffuse distribution across the network, suggesting that systematic
phenotyping may find it more difficult to identify underlying
pathways for these classes of phenotype than for less diffuse
phenotype classes. This is a particular issue for high throughput
phenotyping programmes such as EUMODIC [1] which seek to
relate phenotype to gene function. The diffuseness of phenotypes
could have a number of causes, including limited or biased data
sets, the general pleiotropy of genes underlying some of these
phenotypes or malformed ontologies. The first two of these issues
can be addressed by systematic phenotyping, which can add
missing genes, especially for under-studied phenotypes, and add
additional phenotypes to individual genes, increasing our under-
standing of pleiotropy. To address the third aspect it is possible
that a reconfigured phenotype ontology, based on the GPN and
specifically designed for phenotyping experiments, will be needed.
We illustrate a possible approach to producing a phenotype
ontology structure that more closely reflects the underlying genetic
architecture.
Comparing communities between MP networks and the human
disease gene network shows that there is a many-to-many
relationship between the two types of community. However there
appears to be a closer relationship between phenotype and disease
communities if more granular levels of the MP are used, suggesting
that high throughput phenotyping should aim for the most
granular possible phenotype annotations to maximise their utility.
Materials and Methods
Gene-phenotype association datasets
Gene-phenotype associations and the MP ontology OBO file
were downloaded from MGI [2] via the ftp site on 10.2.2010. The
downloaded files were: ftp://ftp.informatics.jax.org/pub/reports/
MPheno_OBO.ontology and ftp://ftp.informatics.jax.org/pub/
reports/MGI_PhenoGenoMP.rpt.
The MGI_PhenoGenoMP.rpt file, containing the lowest-level
available annotations, was parsed to produce a non-redundant
bipartite graph of gene-phenotype associations. Gene-phenotype
associations obtained from Europhenome were sourced from a
custom-made report of Europhenome gene IDs to MP term links
extracted on 19.1.2010. This was also parsed with the files
provided to produce a non-redundant bipartite graph of gene-
phenotype associations. The two lists were amalgamated to form a
single bipartite edge list of genes to Ensembl IDs. The MP terms
‘‘no phenotypic analysis’’, ‘‘normal phenotype’’, ‘‘no abnormal
phenotype detected’’, ‘‘phenotypic reversion’’, ‘‘reversion by
mitotic recombination’’, ‘‘reversion by viral sequence excision’’
were excluded from the analysis since they were not considered to
convey useful information. Gene dosage was disregarded such that
if either a heterozygote or a homozygote showed a phenotype, the
gene was considered to be associated with the MP term. The MGI
marker IDs and other IDs were converted to Ensembl IDs using
the Ensembl Perl API. Absence of annotation to an MP term could
have two possible causes: either no data has been recorded to
support a given annotation or, because MP does not allow for
annotation of normal phenotypes, they may have been absent but
not annotated. These two states were not distinguished during the
construction of the gene-phenotype network as the relevant
information is not available.
The GO OBO file was downloaded from the GO website on
10.2.2010. The downloaded file was: http://www.geneontology.
org/ontology/obo_format_1_2/gene_ontology.1_2.obo.Gene-GOasso-
ciations were downloaded from Ensembl using the Ensembl
Perl API. OBO files were parsed with a Perl script to give
computational representations of the DAG and the subsequent
analysis of term inheritance.
Construction of gene networks and MP term networks
We mapped all MP terms in the MGI MGI_PhenoGenoMP.rpt
report to their levels in the MP hierarchy. To accommodate mixed
ontology level annotations we elected to focus our analysis on the
most commonly used level of annotation, which was level 5, and
an arbitrarily chosen lower level, level 8, for more granular
annotation.
Gene-phenotype data matrices
A weighted measure of phenotype propensity was used so as to
produce a weighted biadjacency matrix of genes and phenotypes.
This matrix is dependent on the data and the phenotype ontology
structure. Phenotypes were allocated a granularity weight such
that a phenotype was considered more granular if there are more
annotated nodes below it in the ontology. This was
gj~
1
njz1
where gj denotes granularity of phenotype j and nj denotes the
number of terms below term j in the ontology that are annotated
data set.
The weighted gene6phenotype biadjacency matrix B was
calculated by considering the association of a gene with a
phenotype as
bij~
X
k[Tij
gk
Where Tij are all the terms annotated for gene i that are children
nodes of term j at any level below term j. This was done by using
the raw gene-phenotype edge list and converting the MP term
annotation to the desired level and adding the gj weights for each
gene. Cases where MP terms contained multiple parents therefore
produced multiple annotation contributions at higher levels.
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The pairwise association of two genes i1 and i2 for a particular
phenotype j was defined as
pi1i2j~wilcox:test(fbi1j,bi2jg,frest of jg)
ci1i2j~
pi1i2j ai1jw0 ai2jw0
0 otherwise
(
Where Wilcox.test() is a two-sample Wilcoxon test. The values
from the tests were corrected using the fdrtool package in R [36].
A final score di1i2, for two genes was defined as:
di1i2~
1
jPj
X
j
ci1i2j
This is the average value of d over all phenotypes at that level. It
gives a score in the interval [0,1] and served as a metric for gene
associations for all gene pairs. The score was calculated for all gene
pairs and thus produced a i6i matrix that represented the
weighted adjacency matrix for the gene network.
Transposing the matrix A to give A
T gave the biadjacency
matrix with genes as features of phenotypes. Repeating the
procedure gave the weighted adjacency matrix for the phenotype
network.
Parsing of networks
To obtain only the strongest associations, the edge list of the
gene and phenotype networks obtained from the two methods
described above were parsed using at a particular d-value
obtained by inspection of the distribution of d-values in the
network’s edges.
Community extraction from networks
Communities were extracted from networks using Newman’s
spectral method [21]. A C program was adapted from one
provided by the author and this adapted program was incorpo-
rated into the analysis pipeline.
Hubs and hub GO enrichment
Hubs were defined as nodes with a degree in the top 20% of the
node degree distribution in the network that they came from. We
used a one-tailed Fisher’s exact test comparing the GO terms in
each community compared with the appropriate background. The
background was taken to be all the genes in MGI for the
appropriate level, in this case, level 5. The p-values were corrected
using the fdrtool function from the fdrtool package in R [36] for
each category.
Gene expression enrichment
Expression data was obtained from the genome-wide micro-
array analysis of Zhang et al. [37] and from GXD [38,39]. The
microarray files were parsed and the correlation matrix was
calculated. The GXD expression data was taken from a custom
made report in the form of a binary (0,1) matrix of genes6tissues
IDs and a list of tissue ID names.
To represent the associations within communities, a vector was
made that consisted of the union of all pairwise gene associations
within communities for each community. The background control
was based on random re-sampling of gene communities of the
same size sampled randomly from the appropriate original
network’s gene set (nbootstrap=1000). A two-sampled Wilcoxon
test was used on the two vectors by applying the Wilcox.test()
function in R.
Protein-protein interactions
Physical protein-protein interactions (PPI) were taken from
IntAct [40], Biogrid [41], MIPS [42] and DIP [43]. The files down-
loaded were: ftp://ftp.ebi.ac.uk/pub/databases/intact/current/
psimitab/intact.txt, http://www.thebiogrid.org/downloads/data
sets/NCBI.tab.txt and http://mips.gsf.de/proj/ppi/data/mppi.gz.
All files were downloaded on 10.2.2010. The DIP data was
downloaded manually on 22.4.2009.
The Biogrid file was parsed for physical interactions. The
physical interaction experimental systems retained were: ‘‘Affinity
Capture-MS’’, ‘‘Affinity Capture-RNA’’, ‘‘Affinity Capture-West-
ern’’, ‘‘Co-fractionation’’, ‘‘Co-localization’’, ‘‘Co-purification’’,
‘‘FRET’’, ‘‘Two-Hybrid’’, ‘‘Biochemical Activity’’, ‘‘Co-crystal
Structure’’, ‘‘Far Western’’, ‘‘Protein-peptide’’, ‘‘Protein-RNA’’,
‘‘Reconstituted Complex’’.
The protein IDs were converted to Ensembl gene IDs using files
obtained from Ensembl using the Perl API. The separate PPI edge
lists were amalgamated to form a single PPI network.
A random control of the number of PPIs in communities was
obtained by simulating random communities as previously
described for the gene expression enrichment analysis. The
numbers of interactions in random communities were amalgam-
ated to produce a control compared to the real amount with a one-
sampled Wilcoxon test.
GO annotation similarity enrichment
Pairwise GO similarity scores for genes were obtained by using
the adjacency matrix of the level containing the most annotations
and which would provide a compromise between granularity and
amount of annotations. The chosen levels were 5 for BP, CC and
level 2 for MF. The score d was calculated from the biadjacency
matrix for all gene pairs in an adjacency matrix as described for for
the gene expression enrichment analysis.
Treatment and control vectors were obtained as described
previously and a two-sampled Wilcoxon test was used as before to
obtain significance.
Phylogeny data
Phylogenetic data was taken from the Ensembl Compara
database using the Perl API. The data from Ensembl gene tree
objects were parsed to put them in the form of a gene6species
matrix where the elements are integers denoting the copy
number of the genes present in the species. Substituting the row
names of this matrix (Ensembl tree IDs) for mouse genes gave
the required phylogenetic profile matrix for mouse. The
correlation matrix was calculated to obtain all pairwise gene
correlations.
Treatment and control vectors for communities were obtained
from this matrix as previously described.
Assignment of gene communities to highest scoring MP
level 1 groups
The assignment of gene communities to groups defined by
highest scoring MP level 1 phenotypes was done by calculating the
p-value for the probability of each community containing the
overlap with each group defined by highest-scoring MP level 1
phenotype. All pairwise comparisons were made. The probability
mass function that describes the probability of getting z elements
in the intersection set Z is
Mouse Gene-Phenotype Network
PLoS ONE | www.plosone.org 13 May 2011 | Volume 6 | Issue 5 | e19693P(D~z)~P(z;a,b,c,x,y)~
c
z
 !
P min(c{z,x{z)
j~xzc{z{a
c{z
j
 !
a{c
x{z{j
 !
P min(c{z,x{z)
k~yzc{z{b
c{z{j
k
 !
b{c
y{z{k
 !  !
a
x
 !
b
x
 !
where
C~A\B
A jj ~a,B jj ~b,C jj ~c
And we sample X from A of size x and a sample Y from B of size y
such that
X(A
Y(Y
Z~X\Y
X jj ~x,Y jj ~y,Z jj ~z
The cumulative distribution function (CDF) is
P(Dƒz)~CDF(X;a,b,c,x,y)~
X X
z~0
P(z;a,b,c,x,y)
The probability of observing a value as least as extreme as the
observed value is therefore given by
P D§z ðÞ ~PVal z;a,b,c,x,y ðÞ ~1   CDF z   1;a,b,c,x,y ðÞ
which gives the p-value as required. For graphical purposes the
quantity 2log(p) was used as this allows easier differentiation of p-
values. Because community sizes were small in this case, this
probabilistic metric could be calculated but it was computationally
intractable for larger data sets.
Comparison of mouse communities to human
communities
Data from Goh et al were downloaded from http://www.pnas.
org/content/suppl/2007/05/03/0701361104.DC1/01361Table2.
pdf
Newman’s spectral method was applied to extract the
communities. An all-against-all comparison of the communities
was computed using a metric of overlap, p, such that
p~
z
xzz
y
2
where z is the amount of genes overlapping in the two
communities, x is the amount of genes in the first community
and y is the amount of genes in the second community. This is the
average of the fraction of common elements for each set.
Clustering of high-level phenotypes
The gene6phenotype biadjacency binary matrix A described
above for MP level 1 annotations was used to cluster the
phenotypes using the Parpvclust package in R [44], which uses
R’s hclust function to carry out agglomerative hierarchical
clustering. This package calculates approximately unbiased (AU)
bootstrapping to assess the uncertainty in the clustering. The
distance method used was 1-cor(), where cor() is the correlation
operator in R, which calculated Pearson correlation coefficients.
The average linkage method was used and nboot=1 610
4.
Supporting Information
Figure S1 Probability mass for the frequency of annotations at
different levels of the MP in the amalgamated list of gene-
phenotype associations from MGI and Europhenome and the
three GOs in Ensembl.
(TIFF)
Figure S2 Details of example gene communities: A) Community
2 in the MP level 5 gene network. This community visually
corresponds to the community that is frequently annotated with
the granularity level 1 MP term ‘‘hearing/vestibular/ear pheno-
type’’ [MP:0005377] and is highly enriched in the GO terms
‘‘mechanoreceptor differentiation’’ [GO:0042490] and ‘‘sensory
perception’’ [GO:0007600]. B) Community 5 in the MP level 8
gene network. This community visually corresponds to the
community that is frequently annotated with the granularity level
1 MP term ‘‘hematopoietic system phenotype’’ [MP:0005397] and
is highly enriched in the GO terms ‘‘erythrocyte homeostasis’’
[GO:0034101]. Details of example phenotype communities: C)
Example of a phenotype community at level 5, illustrating a
community of phenotypes related to diabetes (in blue). D) Example
of a phenotype community at level 8 illustrating a community pf
phenotypes related to reproductive system abnormalities (in
green).
(TIFF)
Figure S3 Gene and phenotype networks at MP level 8.
Attributes are as in Fig. 1 A–D.
(TIFF)
Figure S4 Topological analysis plots of level 8 networks, with
cut-off. A)–B) Gene network degree distribution and clustering
coefficient for the gene network at MP level 8, dcutoff=0.011. C)–
D) Phenotype Network degree distribution and the clustering
coefficient distribution for the phenotype network at level 8,
dcutoff=0.002. Black lines indicate a line of best fit using linear
regression.
(TIFF)
Figure S5 Topological analysis plots of level 5 gene networks,
with no d cut-off. A–B) Gene network degree distribution and C)
clustering coefficient distribution for the gene network at MP level
1, dcutoff=0. D–F) The same quantities for MP level 5. G–I) The
same quantities for MP level 8. Black lines indicate a line of best fit
using linear regression.
(TIFF)
Figure S6 Topological analysis plots of phenotype networks with
no cut-off. A–B) Gene network degree distribution and C)
clustering coefficient distribution for the gene network at MP
level 5, dcutoff=0. D–F) The same quantities for MP level 8.
(TIFF)
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B) Average clustering coefficient and Newman’s modularity (Q) for
randomly re-wired networks (blue) and the corresponding gene
network at MP level 5 shown in Fig. 4.dcutoff=0.011. The random
networks retain the same degree distribution as the empirical gene
network. C)–D) Average clustering coefficient and Newman’s
modularity (Q) for randomly re-wired networks (blue) and the
corresponding phenotype network at MP level 5 shown in Fig.
dcutoff=0.005.
(TIFF)
Figure S8 Phylogenetic profile correlation in communities.
Shown are probability densities for genes within communities
(red) compared to a random control (black) for the gene networks
presented in the text at level 5 (A) and 8 (B).
(TIFF)
Text S1 Edge list for the gene network at MP level 5 and with
dcutoff=0.009.
(TXT)
Text S2 Edge list for the phenotype network at MP level 5 and
with dcutoff=0.005.
(TXT)
Table S1 Top level MP terms that can form discrete
communities, form communities which fall below the stringency
cut-off (P,0.0001), or do not form communities. Communities are
assessed within the phenotype networks constructed at MP levels 5
and 8, respectively.
(PDF)
Dataset S1 The first worksheet shows the compositions of
Newman communities detected in the GPN at MP level 5 and in
the disease-gene network (showing both human gene composition
and mouse orthologue composition). The second worksheet shows
the genes in the GPN communities that overlap with members of
disease-gene communities, and the disease-gene communities they
are members of.
(XLSX)
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